Henry,
Howdy to all on the thread; been laying off of late due to important versus trivial content. Seems better in recent days.
I doubt HGF will get much press till year end, when preclinical assays and screening should be done. Meanwhile, an "estrogen serum" may be getting press very soon, as it may be the mystery compound from the Lilly deal. You know anything about such compounds, Henry, such as what they might be, and do, and what markets they'd address?
Also, <<<OFF TOPIC>>>, do any threaders have a take on Aurora Biosciences? Management, partners, and technology all look good. Their market is large and they are making sales of their Ultra High Throughput Screening Systems. Jay Silverman of Robbie Stevens likes it. They're ahead of schedule on significant milestones. It's near its lows. I'm really attracted to it. Anyone hear negatives?
Thanks, Tuck |
